Genital Herpes Epidemiology Forecast

DelveInsight's 'Genital Herpes - Epidemiology Forecast to 2030' report delivers an in-depth understanding of the disease, historical and forecasted Genital Herpes epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.


Geographies Covered

  • The United States
  • EU5 (Germany, France, Italy, Spain, and the United Kingdom)
  • Japan


Study Period: 2017-2030


Genital Herpes Understanding

The DelveInsight Genital Herpes epidemiology report gives a thorough understanding of the Genital Herpes by including details such as disease definition, symptoms, causes, pathophysiology, and diagnosis. It also provides treatment algorithms and treatment guidelines for Genital Herpes in the US, Europe, and Japan. The report covers the detailed information of the Genital Herpes epidemiology scenario in seven major countries (US, EU5, and Japan).


Genital Herpes Epidemiology Perspective by DelveInsight

The Genital Herpes epidemiology division provides insights about historical and current patient pool and forecasted trend for every seven major countries. The Genital Herpes epidemiology data are studied through all possible division to give a better understanding of the Disease scenario in 7MM. The Genital Herpes epidemiology segment covers the epidemiology data in the US, EU5 countries (Germany, Spain, Italy, France, and the UK), and Japan from 2017 to 2030. It also helps to recognize the causes of current and forecasted trends by exploring numerous studies, survey reports and views of key opinion leaders.


Genital Herpes Detailed Epidemiology Segmentation

The Genital Herpes epidemiology covered in the report provides historical as well as forecasted Genital Herpes epidemiology scenario in the 7MM covering the United States, EU5 countries (Germany, Spain, Italy, France, and the United Kingdom) and Japan from 2017 to 2030.

The DelveInsight Genital Herpes report also provides the epidemiology trends observed in the 7MM during the study period, along with the assumptions undertaken. The calculated data are presented with relevant tables and graphs to give a clear view of the epidemiology at first sight.


Scope of the Report

  • The Genital Herpes report covers a detailed overview explaining its causes, symptoms, classification, pathophysiology, diagnosis and treatment patterns
  • The Genital Herpes Epidemiology Report and Model provide an overview of the risk factors and global trends of Genital Herpes in the seven major markets (7MM:US, France, Germany, Italy, Spain, UK, and Japan)
  • The report provides insight about the historical and forecasted patient pool of Genital Herpes in seven major markets covering the United States, EU5 (Germany, Spain, France, Italy, UK), and Japan
  • The report helps to recognize the growth opportunities in the 7MM with respect to the patient population
  • The report assesses the disease risk and burden and highlights the unmet needs of Genital Herpes
  • The report provides the segmentation of the Genital Herpes epidemiology


Report Highlights

  • 11-Year Forecast of Genital Herpes epidemiology
  • 7MM Coverage
  • Total Cases of Genital Herpes
  • Total Cases of Genital Herpes according to segmentation
  • Diagnosed cases of Genital Herpes


KOL- Views

We interview, KOLs and SME's opinion through primary research to fill the data gaps and validate our secondary research. The opinion helps to understand the total patient population and current treatment pattern. This will support the clients in potential upcoming novel treatment by identifying the overall scenario of the indications.


Key Questions Answered

  • What will be the growth opportunities in the 7MM with respect to the patient population pertaining to Genital Herpes?
  • What are the key findings pertaining to the Genital Herpes epidemiology across 7MM and which country will have the highest number of patients during the forecast period (2017-2030)?
  • What would be the total number of patients of Genital Herpes across the 7MM during the forecast period (2017-2030)?
  •  Among the EU5 countries, which country will have the highest number of patients during the forecast period (2017-2030)?
  • At what CAGR the patient population is expected to grow in 7MM during the forecast period (2017-2030)?
  • What is the disease risk, burden and unmet needs of the Genital Herpes?
  • What are the currently available treatments of Genital Herpes?


Reasons to buy

  • The Genital Herpes Epidemiology report will allow the user to -
  • Develop business strategies by understanding the trends shaping and driving the global Genital Herpes market
  • Quantify patient populations in the global Genital Herpes market to improve product design, pricing, and launch plans
  • Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Genital Herpes therapeutics in each of the markets covered
  • Understand the magnitude of Genital Herpes population by its epidemiology
  • The Genital Herpes Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources


Key Assessments

  • Patient Segmentation
  • Disease Risk and Burden
  • Risk of disease by the segmentation
  • Factors driving growth in a specific patient population

1. Key Insights 

2. Executive Summary of Genital Herpes

3. Genital Herpes: Disease Background and Overview

3.1. Introduction

3.2. Sign and Symptoms

3.3. Pathophysiology

3.4. Risk Factors

3.5. Diagnosis

4. Patient Journey

5. Epidemiology and Patient Population

5.1. Epidemiology Key Findings

5.2. Assumptions and Rationale: 7MM

5.3. Epidemiology Scenario: 7MM

5.3.1. Genital Herpes Epidemiology Scenario in the 7MM (2017- 2030)

5.4. United States Epidemiology

5.4.1. Genital Herpes Epidemiology Scenario in the United States (2017- 2030)

5.5. EU-5 Country-wise Epidemiology

5.5.1. Germany Epidemiology

5.5.1.1. Genital Herpes Epidemiology Scenario in Germany (2017- 2030)

5.5.2. France Epidemiology

5.5.2.1. Genital Herpes Epidemiology Scenario in France (2017- 2030)

5.5.3. Italy Epidemiology

5.5.3.1. Genital Herpes Epidemiology Scenario in Italy (2017- 2030)

5.5.4. Spain Epidemiology

5.5.4.1. Genital Herpes Epidemiology Scenario in Spain (2017- 2030)

5.5.5. United Kingdom Epidemiology

5.5.5.1. Genital Herpes Epidemiology Scenario in the United Kingdom (2017-2030)

5.6. Japan Epidemiology

5.6.1. Genital Herpes Epidemiology Scenario in Japan (2017- 2030)

6. Treatment Algorithm, Current Treatment, and Medical Practices

6.1. Genital Herpes Treatment and Management

6.2. Genital Herpes Treatment Algorithm

7. KOL Views

8. Unmet Needs

9.  Appendix

9.1. Bibliography

9.2. Report Methodology

10. DelveInsight Capabilities

11. Disclaimer

12. About DelveInsight

*The table of contents is not exhaustive; will be provided in the final report

Table 1  Genital Herpes Epidemiology in 7MM (2017-2030)

Table 2 Genital Herpes Diagnosed and Treatable Cases in 7MM (2017-2030)

Table 3 Genital Herpes Epidemiology in the United States (2017-2030)

Table 4 Genital Herpes Diagnosed and Treatable Cases in the United States (2017-2030)

Table 5 Genital Herpes Epidemiology in Germany (2017-2030)

Table 6 Genital Herpes Diagnosed and Treatable Cases in Germany (2017-2030)

Table 7 Genital Herpes Epidemiology in France (2017-2030)

Table 8 Genital Herpes Diagnosed and Treatable Cases in France (2017-2030)

Table 9 Genital Herpes Epidemiology in Italy (2017-2030)

Table 10 Genital Herpes Diagnosed and Treatable Cases in Italy (2017-2030)

Table 11 Genital Herpes Epidemiology in Spain (2017-2030)

Table 12 Genital Herpes Diagnosed and Treatable Cases in Spain (2017-2030)

Table 13 Genital Herpes Epidemiology in the United Kingdom (2017-2030)

Table 14 Genital Herpes Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Table 15 Genital Herpes Epidemiology in Japan (2017-2030)

Table 16 Genital Herpes Diagnosed and Treatable Cases in Japan (2017-2030)

Figure 1 Genital Herpes Epidemiology in 7MM (2017-2030)

Figure 2 Genital Herpes Diagnosed and Treatable Cases in 7MM (2017-2030)

Figure 3 Genital Herpes Epidemiology in the United States (2017-2030)

Figure 4 Genital Herpes Diagnosed and Treatable Cases in the United States (2017-2030)

Figure 5 Genital Herpes Epidemiology in Germany (2017-2030)

Figure 6 Genital Herpes Diagnosed and Treatable Cases in Germany (2017-2030)

Figure 7 Genital Herpes Epidemiology in France (2017-2030)

Figure 8 Genital Herpes Diagnosed and Treatable Cases in France (2017-2030)

Figure 9 Genital Herpes Epidemiology in Italy (2017-2030)

Figure 10 Genital Herpes Diagnosed and Treatable Cases in Italy (2017-2030)

Figure 11 Genital Herpes Epidemiology in Spain (2017-2030)

Figure 12 Genital Herpes Diagnosed and Treatable Cases in Spain (2017-2030)

Figure 13 Genital Herpes Epidemiology in the United Kingdom (2017-2030)

Figure 14 Genital Herpes Diagnosed and Treatable Cases in the United Kingdom (2017-2030)

Figure 15 Genital Herpes Epidemiology in Japan (2017-2030)

Figure 16 Genital Herpes Diagnosed and Treatable Cases in Japan (2017-2030)

*The table of contents is not exhaustive; will be provided in the final report



  • Tags:
  • Genital Herpes Epidemiology
  • Genital Herpes
  • Genital Herpes Pipeline
  • Genital Herpes Companies
  • Genital Herpes prevalent populatio...
  • Genital Herpes incident population
  • Genital Herpes patients diagnosed
  • Genital Herpes treatment algorithm...

Forward to Friend

Need A Quote